BioSpace News Archive

ViiV’s Two-Drug HIV Treatment Reduces Dosing Regimen, Study Shows

ViiV Healthcare’s two-month injection proved to be as effective as monthly injections for HIV treatment that are currently on the market, the GlaxoSmithKline subsidiary said this morning as it continues to position itself for a leading share of the market alongside Gilead Sciences.

August 22, 2019

·

3 min read

·

Alex Keown

Policy

Novo Nordisk and Mylan Battle Over Generic Versions of Victoza

Novo Nordisk filed a lawsuit in a Delaware district court against generic drugmaker Mylan. The suit is an attempt to block Mylan from marketing a generic version of Novo Nordisk’s diabetes drug Victoza.

August 22, 2019

·

2 min read

·

Mark Terry

Biotech Beach

Research Roundup: Genes Related to Sex Differences in Cancer Aggression and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

August 22, 2019

·

4 min read

·

Mark Terry

Why Mentoring is Important for Biotech Careers

Here are some reasons why mentoring is important for biotech careers.

August 22, 2019

·

4 min read

·

Don Potochny

Biotech Bay

CP Lab Safety and Emery Pharma to Exhibit at American Chemical Society (ACS), BOOTH #1323

Emery Pharma and CP Lab Safety will be attending the American Chemical Society’s National Meeting & Expo in San Diego, California on August 25 – 27, 2019.

August 22, 2019

·

3 min read

Policy

Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention

More Women May Benefit from Hereditary Cancer Risk Assessment and Genetic Testing

August 22, 2019

·

7 min read

Deals

Freeze and Thaw Systems Market Continues to Benefit from Biopharma Companies, Gains Remain Concentrated in ‘Disposable’ Systems

A report on the freeze & thaw systems market which considers the global industry analysis 2014 – 2018 and forecast 2019-2029 projects that, the freeze & thaw systems market is expected to reach ~ US$ 270 Mn by the end of 2019 in terms of value, and is forecasted to reach ~ US$ 550 Bn by the end of 2029.

August 22, 2019

·

3 min read

Biotech Beach

Exploring the Next Global Developments in Health Innovation

CEOs Share Breakthroughs, Insights and Opportunities at “Think Asia, Think Hong Kong” Symposium

August 22, 2019

·

4 min read

Lone Star Bio

An Unlikely New Target for Glioblastoma Drugs Found

Researchers led by Texas A&M University’s College of Veterinary Medicine & Biomedical Sciences have identified a new pathway they believe may help suppress the development of glioblastoma tumors.

August 22, 2019

·

3 min read

·

Mark Terry

Drug Development

Clinical Catch-up for August 19-23

Biopharma companies large and small are involved in numerous clinical trials. Here’s a look at some of the top stories from last week.

August 22, 2019

·

6 min read

·

Mark Terry